Acer Therapeutics Inc Asset Turnover Ratio (ACER), as of third quarter 2023, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Acer Therapeutics Inc   (ACER)
 

Acer Therapeutics Inc Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Acer Therapeutics Inc asset turnover ratio, the ability of Acer Therapeutics Inc 's assets to generate revenue in the third quarter 2023, increased sequentially to 0.03 in the third quarter (Sep 30 2023), ACER's balance sheet remain strong.

Within sector Acer Therapeutics Inc achieved the highest asset turnover ratio. While asset turnover ranking remained unchanged in the Third Quarter 2023 compared to previous quarter at no. .

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ACER Asset Turnover Ratio (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Asset Change -8.63 % -36.98 % -50.2 % -67.94 % -52.92 %
Y / Y Revenue Change - - - - -
Asset Turnover Ratio (TTM) 0.03 - - - -
ACER's Total Ranking # # # # #
Seq. Asset Change -4.41 % -6.53 % 34.82 % -24.15 % -34.07 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall Market #

Asset Turnover Ratio Statistics
High Average Low
0 0 0
 




ACER Company Profile • Back to ACER Efficiency Comparisons • Compare ACER Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2023, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2023 Assets at quarter ending Sep 30 2023
Femasys Inc   0.07 $ 1.093  Millions$ 14.983  Millions
Recursion Pharmaceuticals Inc   0.07 $ 47.360  Millions$ 656.545  Millions
4d Molecular Therapeutics Inc   0.07 $ 21.989  Millions$ 304.996  Millions
Igc Pharma Inc   0.07 $ 1.343  Millions$ 19.048  Millions
Hcw Biologics Inc   0.07 $ 2.859  Millions$ 41.361  Millions
Tscan Therapeutics Inc   0.07 $ 16.933  Millions$ 245.243  Millions
Vbi Vaccines Inc  0.07 $ 8.122  Millions$ 118.163  Millions
Northwest Biotherapeutics Inc  0.07 $ 2.084  Millions$ 31.031  Millions
Abvc Biopharma Inc   0.06 $ 0.739  Millions$ 11.626  Millions
Solana Company  0.06 $ 0.792  Millions$ 12.662  Millions
Beam Therapeutics Inc   0.06 $ 81.554  Millions$ 1,329.622  Millions
Lyell Immunopharma Inc   0.06 $ 48.503  Millions$ 862.089  Millions
Cervomed Inc   0.05 $ 1.526  Millions$ 28.712  Millions
C4 Therapeutics Inc   0.05 $ 20.349  Millions$ 383.724  Millions
Tff Pharmaceuticals Inc  0.05 $ 0.932  Millions$ 17.697  Millions
Clearside Biomedical Inc   0.05 $ 2.211  Millions$ 42.401  Millions
Ideaya Biosciences Inc   0.05 $ 23.484  Millions$ 453.304  Millions
Asensus Surgical Inc   0.05 $ 4.667  Millions$ 90.419  Millions
Bicycle Therapeutics Plc  0.05 $ 24.830  Millions$ 483.066  Millions
Celularity Inc   0.05 $ 14.788  Millions$ 291.773  Millions
Atara Biotherapeutics Inc   0.05 $ 13.578  Millions$ 278.433  Millions
Vir Biotechnology Inc   0.05 $ 118.803  Millions$ 2,439.198  Millions
Editas Medicine Inc   0.05 $ 24.611  Millions$ 506.257  Millions
Cue Biopharma Inc   0.05 $ 3.820  Millions$ 78.754  Millions
Gritstone Bio Inc   0.05 $ 10.225  Millions$ 215.137  Millions
Verrica Pharmaceuticals Inc   0.05 $ 3.204  Millions$ 68.177  Millions
Vystar Corporation  0.05 $ 0.417  Millions$ 9.103  Millions
Quantum Cyber N v   0.05 $ 0.874  Millions$ 19.248  Millions
Syros Pharmaceuticals Inc   0.05 $ 8.795  Millions$ 194.647  Millions
Roivant Sciences Ltd   0.04 $ 103.153  Millions$ 2,294.230  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.